Summary: Radiofrequency ablation is a well-established treatment tool utilized in musculoskeletal oncology. It is a safe, minimally invasive, and cost-effective treatment for many lesions. Most frequently utilized for treating osteoid osteomas, the technique is also helpful for controlling selected lesions from metastatic bone disease and other benign bone disorders, such as, chondroblastomas and osteoblastomas. The procedure requires considerable preoperative planning and organization to assure a smooth, efficient experience. Our intent is to review the indications for radiofrequency ablation as a treatment option for musculoskeletal tumors and to give a detailed description of the planning, set-up and technique of the procedure.
Radiofrequency ablation (RFA) is a relatively new technique for the treatment of bone tumors that offers reduced morbidity with excellent success. In RFA, alternating current (100 -500 kHz) is delivered to pathologic tissue by the probe tip. This causes ionic agitation and frictional heat that causes local tissue coagulation in a small area around the tip of the probe.
Many companies are currently distributing RFA devices for clinical use including: Boston Scientific, RITA Medical System, Radionics, Tyco Healthcare, and Berchtold Medical Electronics. Although the RITA and Radionics devices are most well known to these authors, a similar tissue response and safety profile can be expected from all approved devices (Figs. 1 and 2). The RITA device consists of a 50 to 150 W alternating current generator and a 15-gauge electrode. The probe has a movable hub and eight retracting curved electrodes that are deployed from the tip after its positioning into the tumor. An array electrode can increase the coagulation zone enabling a higher rate of complete necrosis. The probe tips can be seen on computed tomography (CT) scan and can be adjusted based on the area intended to treat. Each needle tip can also register the temperature in the heated area. Radionics distributes a probe that consists of a straight needle with an internal channel. Inside this channel, saline solution circulates for cooling. Holes are present to permit the leakage of saline solution to increase tissue conductivity.
Radiofrequency ablation is most often used for treating osteoid osteomas, but its indications are expanding to include other benign and malignant lesions such as chondroblastoma and metastatic bone disease. Osteoid osteoma is a benign, bone-forming tumor that most commonly occurs in children and young adults. It classically produces pain that is worse at night and relieved by anti-inflammatory medication. The nidus in the center of the tumor rarely exceeds 1.5 cm in diameter. 2 Classically, they arise in diaphyseal bone, however, they have also been reported in the epiphyseal and metaphyseal bone of the axial and appendicular skeleton. 11 Although there is evidence that many of these lesions will regress spontaneously, patients are usually unwilling or cannot tolerate prolonged NSAID use and the unpredictable duration of the disease.
Historically, these lesions were widely excised with open surgical procedures. 18, 19 The development of less invasive techniques have been explored by many authors to avoid the complications of wide open excision such as infection, soft tissue damage, creation of a stress riser, increased postoperative pain, and difficulty finding the lesion. 16 It is also more cost effective. 3 Radiofrequency ablation provides an attractive alternative to open excision of the nidus and is a superior alternative for most uncomplicated cases of osteoid osteoma. In addition, RFA is well established as having a high success rate with a low incidence of complications. 4, 15 This is true for both primary lesions and recurrences after attempted open surgical procedures. 13 It is our intent to share with the orthopaedic community our preoperative thought process, a detailed step-by step account of our room set-up and procedure, and what to expect postoperatively.
INDICATIONS FOR RFA FOR BONE LESIONS
In addition to using RFA for osteoid osteoma, reports of using computed tomography (CT) guided-RFA for the treatment of other bone lesions are increasing. Bone metastasis measuring as large as 7 cm in size have been treated successfully with this technique. 6 Radiation therapy is the current standard of care for local treatment of tumors, however, it may be contraindicated or not effective for pain relief. Many physicians are considering RFA an option for pain relief in metastatic disease because of the reasonable early results and reduced morbidity for the patient 12, 20 Kojima et al. have also showed good pain relief using RFA for the treatment of metastatic bone lesions. 14 Good outcomes with pain relief have also been reported with radiofrequency ablation of spine metastases. 7, 8 In 2004 Goetz et al. reported on 31 patients who where treated with RFA of metastatic disease for pain relief. A multi-tip needle probe was inserted into the lesion and heated to 100°C for 5 minutes. Pain scores decreased from an average of 7.9/10 before the procedure to 3.0/10 and 1.4/10 at 12 and 24 weeks, respectively, after the procedure. Opioid usage was also significantly decreased. Three complications were noted including a skin burn from the ground pad, transient bowel and bladder incontinence from treatment of a sacral lesion, and an acetabular fracture after treatment of an acetabular lesion. 1 The minimally invasive technique used with CTguided RFA has increased the armamentarium for treating difficult to access lesions. A primary example would be chondroblastoma of the femoral head. Although complication rates may be significant because of the close proximity of the probe tip to the joint surface, this technique may be an attractive option compared with an open procedure. 17 Open treatment of chondroblastoma of the femoral head poses a significant risk to the vascularity of the femoral head, the articular cartilage, the growth plate, and also increase the risk for postoperative fracture. Osteoblastoma may also be treated with RFA in the future with multiple sites of treatments or a larger probe to target the larger lesion. There is limited data in the literature to truly know the efficacy for lesions other than osteoid osteomas and metastatic bone disease. One must be careful in applying this technique without careful preoperative diagnostic imaging since tissue cannot reliably be obtained for definitive histologic diagnosis.
PREOPERATIVE EVALUATION
Diagnosis of bone lesions is beyond the scope of this review, but it cannot be overstated the importance of the initial patient evaluation at arriving at an accurate clinical and radiographic diagnosis. Patients with osteoid osteomas will frequently present with a classic history of pain relieved by NSAIDs, but this will not be true in all cases. Radiographic assessment with thin cut CT with coronal and sagital reconstructions will usually identify the nidus of an osteoid osteoma better than magnetic resonance imaging (MRI). Bone scans are useful for targeting the lesions when plain radiographs do not demonstrate the lesion. It is not uncommon in the pediatric population to have varied lower extremity pain complaints secondary to referred pain that can lead to many unnecessary imaging modalities on incorrect regions of the patient. A dynamic contract CT can also be used when trying to distinguish between a nidus of osteoid osteoma and a Brodie's abscess.
PREOPERATIVE PLANNING
Once a lesion amenable to RFA is found and the diagnosis is confirmed radiographically, the patient can be scheduled for outpatient radiofrequency ablation. The procedure usually takes approximately 1 to 1.5 hours and requires the collaborative efforts of the radiology, anesthesia, and operating room staff. All anesthesia equipment and the sterile equipment needed for the procedure are brought into the room with the CT scanner. It is useful to have a checklist to be assured that all personnel, rooms, and equipment necessary for the procedure will be available (Table  1 ). This will increase the efficiency of the procedure and help avoid frustration. For larger patients make sure the weight limit of the CT table can safely support the patient.
The surgeon should preoperatively plan the starting position and angles anticipated to safely and accurately enter the lesion using X-rays or CT scans if available.
FIG. 2. Radionics equipment (A)
Binopty biopsy/drill set insert, (B) radionics probe through binopty cannulated system, (C) radionics radiofrequency generator.
Areas with important neurovascular structures should be avoided if possible because working around these structures can lead to inadvertent injury. Open surgical removal of the nidus should be considered if it is within 1 or 1.5 cm of important neurovascular structures. 5, 18 The skin should also be respected as severe burns have been reported. 10 When planning a point of entry for the bone introducer or drill bit it is helpful to choose a flat bone surface that is perpendicular to the lesion. To avoid neurovascular structures and to assist with patient positioning it is not uncommon to drill through the anterior cortex of a bone to get to the lesion on the posterior cortex.
PROCEDURE ROOM SET-UP
It is preferable to have a large CT room to house all of the equipment, and personnel needed to safely perform the procedure (Fig. 3) . A sterile table will be needed for the surgical equipment and space will also be needed for the anesthesia and RF ablation machines. The anesthesiologist and anesthesia machine are preferably on the opposite side of the patient from the surgeon to allow for maximum access to the patient and to reduce the chance for sterile table contamination. A radiology technician, circulation nurse, anesthesiologist, and surgeon are usually the only people needed, however, a radiologist and surgical assistant may also be an asset.
The sterile surgical equipment that should be available is: skin prep solution, draping supplies, local anesthetic, number 11 blade, gauze, drill with multi-size drill bits, bone introducer, RF probe and cord, saline, suture, and dressings (Fig. 4A) . Confirm that all equipment is present and working properly before any anesthesia is administered. Two dispersion (grounding) pads should be placed on the patient with good skin contact. The pads should be placed approximately equidistant and in opposite directions from the operative site. Correct placement of these pads is a critical step in the procedure and should not be delegated to other members of the team. This step should follow strict product manufacturing recommendations (see Appendix at end of article).
ANESTHESIA
General anesthesia or a spinal block is generally preferred to conscious sedation and local anesthesia for both the comfort of the patient and facilitation of ablating the lesion. Younger patients can often remain anxious with sedation even if they are pain free because of the unfamiliar environment and emotional stress of the procedure. In addition, patients will often uncontrollably move the effected limp during the ablation or imaging stages that can result in movement of the probe or additional radiation exposure needed.
PATIENT POSITIONING AND LESION TARGETING
Once the patient is under anesthesia, the next task is to determine the correct starting point. The anticipated path that the probe will follow should be planned preoperatively. A grid can be placed on the patient's skin over the working area before the first CT scan to help with localization of a starting point (Fig. 4B) . Markings on the grid can be seen on the CT scan and can be used to estimate distance across the skin (Fig.  5A ). For example, the starting point may be between the 3rd and 4th line on the grid in the medial to lateral direction. Proximal to distal movements can be estimated by using the CT slice thickness and counting how many images the lesion is from a point of reference.
CT TECHNIQUE
Before beginning the procedure, a dose of intravenous prophylactic antibiotic is given to the patient. A first generation cephalosporin or equivalent is appropriate. Once the patient is anesthetized and on the CT table, a preliminary study is done with wide cuts (3.0 mm cuts) to localize the lesion. Next, the imaging area is narrowed and the slice width is decreased to 1 mm sections to assist with targeting the center of the lesion. The small area to be ablated can be repeatedly scanned when drilling to confirm that the angles and depth of drilling is correct.
FIG. 5.
Step-by-step RFA procedure. (A) Initial scout with skin grid for targeting lesion, (B) mark skin using lights from scanner, (C) drill into cortical bone, (D) place bone introducer through cortical hole made with drill bit, (E) CT image with bone introducer, (F) place ablation probe through introducer, (G) CT image with probe in center of lesion, (H) add saline to the system to lower impendence, (I) start ablation 90°C for 4 to 6 minutes. Lead is usually not required for the procedural team as the surgeon can safely and sterilely enter the CT control room during scanning. Retreat into the control room also allows the surgeon to read the images in real time to make any adjustments of the probe. A lead apron usually can be placed on the patient except in certain pelvic or sacral lesions.
BONE INTRODUCER PLACEMENT
After the skin is marked the region can be prepped and draped for the procedure (Fig. 5B ). An 11 blade is used to puncture the skin and the bone introducer can be placed. If thick cortical bone needs to be penetrated to access the lesion, a drill bit will be necessary to facilitate placement of the introducer. A drill guide should be inserted to protect soft tissue and pressed firmly against the bone. A 3.5 mm drill hole should be made in the near cortex (Fig. 5C ). The bone introducer can then be inserted into the hole and advanced at the presumed angle necessary to enter the center of the lesion (Fig. 5D ). Once resistance is encountered, a repeat CT should be done to confirm that the needle is pointing toward the lesion (Fig.  5E) . A goniometer can be used on the CT monitor to estimate any adjustments to precisely adjust the angle of advancement into the lesion.
Once the tip of the introducer is confirmed in the center of the lesion, the center portion can be removed and a core biopsy of bone can be removed and sent for pathology evaluation. This is often not done, however, because it usually does not change management and the core biopsy frequently does not yield adequate tissue to make a diagnosis. 18 
PROBE PLACEMENT AND RFA
The tip of the RF probe can then be inserted into the introducer and advanced to the lesion (Fig. 5F ). This tip position should also be confirmed with another CT image to assure the final position is correct (Fig. 5G) . Several tips are available including a single tip probe to precisely deliver heat from one point and a multi-tip that has an umbrella type array of electrodes at the end for a larger area of treatment. The divergence of the probes on the multi-tip can be adjusted to broaden or narrow the area of treatment and the individual probes can usually be seen on CT. This is one of the key differences among manufactures. Rita medical systems only use umbrellatype multi-tip probes and Radionics only has single-tip probes. For treatment of an osteoid osteoma, a single probe with approximately 5 mm of exposed tip is all that is required since the nidus is Ͻ1.5 cm. When treating metastatic bone disease the lesions vary substantially in size and having a multi-tip probe becomes handy and allows for a broader area of tissue necrosis with each RFA cycle. With the tip of the probe in position, the correct end of the cord can be passed off and plugged into the RF machine. The cord should be secured to the patient with one or two clamps to avoid any traction while the CT table moves in and out of the scanner. All equipment should be inspected before each CT scan is performed to assure it will not be incidentally displaced when the table moves into the scanner. It is important to add saline to the system to help decrease impedance and facilitate ablation without over "cooking" the lesional area (Fig. 5H) .
The settings on the RF machine we use are 90°C for 4 to 6 minutes with a power of 100. The machine will slowly raise the temperature and start a timer when 90°C is reached (Fig. 5I) . After the 4 to 6 minutes is complete, the machine will cool down back to room temperature. The probe can usually be removed before cool down finishes. Rosenthal et al. use these same parameters for treatment of osteoid osteomas. 2 There is more discrepancy in length of ablation time than ablation temperature from institution to institution. Ablation times vary from 2 to 8 minutes. The only basic research evaluating the zone of tumor necrosis or kill is based on one dog study that demonstrated approximately a 1 cm necrosis zone from the tip of the probe when using 80°C for 4 minutes.
SPECIFIC CONSIDERATIONS BASED ON LOCATION OF TUMOR
RFA of spinal lesions put the dura and neural structures at risk therefore conscious sedation and local anesthesia is preferable in this setting to allow better monitoring of the patients. 9 Complications can be reduced by interrupting treatment or repositioning the probe if local temperature rise begins to cause symptoms. Gronemeyer et al. used RFA to treat 10 spine lesions ranging from 1.5 cm to 9 cm with good pain relief and no complications. 7 Chondroblastomas located in the femoral head is another possible indication for RF ablation. To address this lesion with an open procedure would pose significant risk to the articular cartilage, the growth plate, and the vascular supply to the femoral head. CT-guidance can allow for accurate placement of an introducer and ablation probe to treat the lesion with significantly less morbidity and risk.
Osteoblastoma may also be treated with RFA. Because osteoblastomas can usually range from 1.5 to 2 cm in size, they may need to be treated with a multi-tip array probe to increase the treatment area to cover the whole lesion. 13 
POSTOPERATIVE CARE
Compared with surgical removal of a lesion, radiofrequency ablation offers a quicker, safer return to preoperative function. The creation of a stress riser because of bone removal is decreased with RF ablation therefore patients can usually weight bear as tolerated and return to normal activities as they feel comfortable. Hospital stay is also reduced and a majority of these patients can go home the same day because of less anesthesia time and less insult to the procedure site. Overnight admission is uncommon after this procedure but may be necessary in a select few patients with uncontrolled pain. Pain is usually greatest in the immediate postoperative period because of the local necrosis but this should become much more tolerable in the first 24 hours. Most patients will be off pain relieving medications within a week of the procedure. Patients are seen two weeks postoperatively to check their incision, remove sutures if used, and for a postoperative radiograph. Patients with superficial lesion locations should especially be assessed for skin necrosis and should be seen at a shorter initial postoperative follow up interval. The majority of patients treated for an osteoid osteoma will be pain-free at this time interval and completely off medication. A short-term follow up is useful at 3 months postprocedure and then a follow up at 1 year with a new radiograph is offered to the patient. There are no studies that have addressed the long-term radiographic follow up of patients with an osteoid osteoma treated with RFA. Many patients will ask what will happen to the lesion on the follow-up radiographs. There is no data in the literature to help answer this question and is an area for future research.
PEARLS AND PITFALLS
• RFA is indicated for use in treating osteoid osteomas, metastatic bone disease, and some other bone lesions.
• Planning and organization are crucial to having a successful experience.
• Placement of the dispersion (grounding) pads is important to prevent heat related complications of the procedure.
• Larger lesions may require multiple ablation cycles and repositioning of probe for optimum results.
• Return to preoperative activity level is rapid and it is uncommon to need any restrictions on activity level.
